These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase. Dong MS; Yamazaki H; Guo Z; Guengerich FP Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680 [TBL] [Abstract][Full Text] [Related]
4. Electrostatic interaction between cytochrome P450 and NADPH-P450 reductase: comparison of mixed and fused systems consisting of rat cytochrome P450 1A1 and yeast NADPH-P450 reductase. Kondo S; Sakaki T; Ohkawa H; Inouye K Biochem Biophys Res Commun; 1999 Apr; 257(2):273-8. PubMed ID: 10198202 [TBL] [Abstract][Full Text] [Related]
5. Structure and function of NADPH-cytochrome P450 reductase and nitric oxide synthase reductase domain. Iyanagi T Biochem Biophys Res Commun; 2005 Dec; 338(1):520-8. PubMed ID: 16125667 [TBL] [Abstract][Full Text] [Related]
6. Residue 285 in cytochrome P450 2B4 lacking the NH(2)-terminal hydrophobic sequence has a role in the functional association of NADPH-cytochrome P450 reductase. Schulze J; Tschöp K; Lehnerer M; Hlavica P Biochem Biophys Res Commun; 2000 Apr; 270(3):777-81. PubMed ID: 10772901 [TBL] [Abstract][Full Text] [Related]
7. [NADPH-cytochrome P450 reductase, not only the partner of cytochrome P450]. Wiśniewska A; Jagiełło K; Mazerska Z Postepy Biochem; 2009; 55(3):272-8. PubMed ID: 19928583 [TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of benzoate-para-hydroxylase, a cytochrome P450 (CYP53A1), from Aspergillus niger. Faber BW; van Gorcom RF; Duine JA Arch Biochem Biophys; 2001 Oct; 394(2):245-54. PubMed ID: 11594739 [TBL] [Abstract][Full Text] [Related]
9. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase. Roitel O; Scrutton NS; Munro AW Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506 [TBL] [Abstract][Full Text] [Related]
10. Purification and functional analysis of fungal nitric oxide reductase cytochrome P450nor. Zhang L; Shoun H Methods Enzymol; 2008; 437():117-33. PubMed ID: 18433626 [TBL] [Abstract][Full Text] [Related]
11. The roles of cytochrome b5 in cytochrome P450 reactions. Porter TD J Biochem Mol Toxicol; 2002; 16(6):311-6. PubMed ID: 12481306 [TBL] [Abstract][Full Text] [Related]
12. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495 [TBL] [Abstract][Full Text] [Related]
13. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification. Chun YJ; Shimada T; Guengerich FP Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703 [TBL] [Abstract][Full Text] [Related]
14. AFM study of membrane proteins, cytochrome P450 2B4, and NADPH-cytochrome P450 reductase and their complex formation. Kiselyova OI; Yaminsky IV; Ivanov YD; Kanaeva IP; Kuznetsov VY; Archakov AI Arch Biochem Biophys; 1999 Nov; 371(1):1-7. PubMed ID: 10525282 [TBL] [Abstract][Full Text] [Related]
15. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3. Sevrioukova I; Shaffer C; Ballou DP; Peterson JA Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531 [TBL] [Abstract][Full Text] [Related]
16. Oxidative aldehyde deformylation catalyzed by NADPH-cytochrome P450 reductase and the flavoprotein domain of neuronal nitric oxide synthase. Vatsis KP; Coon MJ Biochem Biophys Res Commun; 2005 Dec; 337(4):1107-11. PubMed ID: 16226717 [TBL] [Abstract][Full Text] [Related]
17. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5. Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180 [TBL] [Abstract][Full Text] [Related]
18. The interaction of NADPH-P450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain. Estabrook RW; Shet MS; Fisher CW; Jenkins CM; Waterman MR Arch Biochem Biophys; 1996 Sep; 333(1):308-15. PubMed ID: 8806785 [TBL] [Abstract][Full Text] [Related]
19. Relationship between cytochrome P450 catalytic cycling and stability: fast degradation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) in hepatoma cells is abolished by inactivation of its electron donor NADPH-cytochrome P450 reductase. Zhukov A; Ingelman-Sundberg M Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):453-8. PubMed ID: 10333489 [TBL] [Abstract][Full Text] [Related]
20. Stopped-flow kinetic studies of electron transfer in the reductase domain of neuronal nitric oxide synthase: re-evaluation of the kinetic mechanism reveals new enzyme intermediates and variation with cytochrome P450 reductase. Knight K; Scrutton NS Biochem J; 2002 Oct; 367(Pt 1):19-30. PubMed ID: 12079493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]